SNST (Aphex BioCleanse Systems) EBITDA Margin %: 0.00% (As of . 20)


What is Aphex BioCleanse Systems EBITDA Margin %?

Aphex BioCleanse Systems SNST EBITDA Margin % is 0.00% as of . 20.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Aphex BioCleanse Systems's EBITDA for the three months ended in . 20 was $0.00 Mil. Aphex BioCleanse Systems's Revenue for the three months ended in . 20 was $0.00 Mil. Therefore, Aphex BioCleanse Systems's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Aphex BioCleanse Systems  (OTCPK:SNST) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Aphex BioCleanse Systems EBITDA Margin % Related Terms

Aphex BioCleanse Systems EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Aphex BioCleanse Systems's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aphex BioCleanse Systems EBITDA Margin % Chart

Aphex BioCleanse Systems Annual Data
Trend
EBITDA Margin %

Aphex BioCleanse Systems Quarterly Data
EBITDA Margin %

Aphex BioCleanse Systems EBITDA Margin % Competitor Comparison

For the Household & Personal Products subindustry, Aphex BioCleanse Systems's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aphex BioCleanse Systems EBITDA Margin % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aphex BioCleanse Systems's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Aphex BioCleanse Systems's EBITDA Margin % falls into.


Aphex BioCleanse Systems EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Aphex BioCleanse Systems's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Aphex BioCleanse Systems's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Aphex BioCleanse Systems (SNST) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aphex BioCleanse Systems and its competitors.
Is Aphex BioCleanse Systems' EBITDA Margin % too high?
Aphex BioCleanse Systems' current EBITDA Margin % is 0.00%.
How does Aphex BioCleanse Systems' EBITDA Margin % compare to competitors?
Aphex BioCleanse Systems' EBITDA Margin % of 0.00% can be compared against companies in the Consumer Packaged Goods industry. The industry median EBITDA Margin % is 8.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.99, based on 1,953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aphex BioCleanse Systems and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aphex BioCleanse Systems's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aphex BioCleanse Systems stock overvalued right now?
Aphex BioCleanse Systems (SNST) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Aphex BioCleanse Systems (SNST), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aphex BioCleanse Systems Business Description

Address 1820 State Road 13, Unit 11-43, Saint Johns, FL, USA, 32259
Aphex BioCleanse Systems Inc is a United States-based company that provides sanitization solutions. It develops and manufactures non-alcohol, non-toxic, and hydrogen-based disinfecting technology. The company produces proprietary hydrogen-based disinfectant and pesticide products known as Hy-IQ Water.